Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;33(2):271-280.
doi: 10.1038/s41379-019-0330-9. Epub 2019 Aug 1.

Molecular characterization of localized pleural mesothelioma

Affiliations

Molecular characterization of localized pleural mesothelioma

Yin P Hung et al. Mod Pathol. 2020 Feb.

Abstract

Localized pleural mesothelioma is a rare solitary circumscribed pleural tumor that is microscopically similar to diffuse malignant pleural mesothelioma. However, the molecular characteristics and nosologic relationship with its diffuse counterpart remain unknown. In a consecutive cohort of 1110 patients with pleural mesotheliomas diagnosed in 2005-2018, we identified six (0.5%) patients diagnosed with localized pleural mesotheliomas. We gathered clinical history, evaluated the histopathology, and in select cases performed karyotypic analysis and targeted next-generation sequencing. The cohort included three women and three men (median age 63; range 28-76), often presenting incidentally during radiologic evaluation for unrelated conditions. Neoadjuvant chemotherapy was administered in two patients. All tumors (median size 5.0 cm; range 2.7-13.5 cm) demonstrated gross circumscription (with microscopic invasion into lung, soft tissue, and/or rib in four cases), mesothelioma histology (four biphasic and two epithelioid types), and mesothelial immunophenotype. Of four patients with at least 6-month follow-up, three were alive (up to 8.9 years). Genomic characterization identified several subgroups: (1) BAP1 mutations with deletions of CDKN2A and NF2 in two tumors; (2) TRAF7 mutations in two tumors, including one harboring trisomies of chromosomes 3, 5, 7, and X; and (3) genomic near-haploidization, characterized by extensive loss of heterozygosity sparing chromosomes 5 and 7. Localized pleural mesotheliomas appear genetically heterogeneous and include BAP1-mutated, TRAF7-mutated, and near-haploid subgroups. While the BAP1-mutated subgroup is similar to diffuse malignant pleural mesotheliomas, the TRAF7-mutated subgroup overlaps genetically with adenomatoid tumors and well-differentiated papillary mesotheliomas, in which recurrent TRAF7 mutations have been described. Genomic near-haploidization, identified recently in a subset of diffuse malignant pleural mesotheliomas, suggests a novel mechanism in the pathogenesis of both localized pleural mesothelioma and diffuse malignant pleural mesothelioma. Our findings describe distinctive genetic features of localized pleural mesothelioma, with both similarities to and differences from diffuse malignant pleural mesothelioma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest There is no disclosure from YPH, FD, AMD and PDC. RB has served on the Advisory boards for Myriad, Exosome Diagnostics, and CollaboRx and received support from the National Cancer Institute and investigator-initiated industry grants from Castle Biosciences, Exosome Diagnostics, Genentech-Roche, Gritstone, HTG, Merck, Myriad, Novartis, PamGene, Siemens, Verastem, MedGenome, and Epizyme. LRC undertakes medicolegal work related to mesothelioma. All financial disclosures listed above do not apply to the current study, which is not associated with a specific source of funding.

Figures

Fig. 1
Fig. 1
Clinicopathologic and molecular features of the six localized pleural mesotheliomas. B biphasic, E epithelioid, F female, M male, VUS, variant of uncertain significance
Fig. 2
Fig. 2
BAP1-mutant localized pleural mesothelioma (Case 1). a Computed tomography demonstrated a circumscribed pleural mass in the right upper lobe. b Grossly, the tumor was solitary with no evidence of serosal spread. c The tumor showed biphasic histology with both epithelioid and sarcomatoid components, histologically indistinguishable from diffuse malignant pleural mesothelioma (hematoxylin and eosin, 200×). By immunohistochemistry, tumor cells expressed calretinin (d) and WT1 (e) and showed complete loss of nuclear BAP1 expression (f), with positive control BAP1 staining in the background stromal and inflammatory cells. g Single nucleotide polymorphism array analysis (top) showed homozygous deletion of CDKN2A at 9p (close-up: bottom left) and hemizygous deletion of NF2 at 22q (close-up: bottom right)
Fig. 3
Fig. 3
Localized pleural mesothelioma with trisomies of chromosomes 3, 5, 7, and X (Case 4). a A scanning photomicrograph demonstrated a circumscribed solitary tumor (hematoxylin and eosin). b The tumor showed epithelioid histology, characterized by a tubular and nested pattern (100×) and c occasional vacuoles (400×). Tumor cells demonstrated calretinin (d) and WT1 (e) immunoreactivity. Mucicarmine stains, without (f) and with (g) hyaluronidase treatment, confirmed the presence of hyaluronic acid. h Single nucleotide polymorphism array analysis showed select gains of chromosomes 3, 5, 7, and X (arrows), with karyotypic analysis (i) confirming trisomies of chromosomes 3, 5, 7, and X (arrows)
Fig. 4
Fig. 4
BAP1-wild-type TRAF7-wild-type localized pleural mesothelioma with genomic near-haploidization sparing chromosomes 5 and 7 (Case 5). a A low power image (hematoxylin and eosin, 40×) demonstrated a circumscribed pleural mass adjacent to the lung. Histologically, tumor cells showed both epithelioid component (b), characterized by epithelioid cells in a tubular and solid pattern, and sarcomatoid component (c), with intermixed hyperchromatic spindle tumor cells and chronic inflammation (400×). Tumor cells demonstrated diffuse calretinin (d), patchy WT1 (predominantly in a nucleolar pattern) (e), and patchy D2-40 (f) immunoreactivity. g Copy number VisCap plot and h a plot of variant allele fraction in the targeted genome demonstrated extensive loss of heterozygosity in all chromosomes except 5 and 7 (arrows)

Similar articles

Cited by

References

    1. Churg A, Roggli V, Chirieac LR, Galateau-Salle F, Borczuk AC, Dacic S, et al. Tumours of the pleura. Mesothelial tumours. Localized malignant mesothelioma In: Travis WD, Brambilla E, Burke A, Marx A, Nicholson AG, editors. World Health Organization Classification of tumors pathology and genetics of tumors of the lung, pleura, thymus, and heart. 4th edn Lyon, France: IARC Press; 2015. p. 170.
    1. Allen TC, Cagle PT, Churg AM, Colby TV, Gibbs AR, Hammar SP, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866–73. - PubMed
    1. Okike N, Bernatz PE, Woolner LB. Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg. 1978;75:363–72. - PubMed
    1. Crotty TB, Myers JL, Katzenstein AL, Tazelaar HD, Swensen SJ, Churg A. Localized malignant mesothelioma. A clinicopathologic and flow cytometric study. Am J Surg Pathol. 1994;18:357–63. - PubMed
    1. Nakano T, Hamanaka R, Oiwa K, Nakazato K, Masuda R, Iwazaki M. Localized malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2012;60:468–74. - PubMed

MeSH terms

Substances

LinkOut - more resources